The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Clovis Oncology; Pfizer
Research Funding - Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer
Travel, Accommodations, Expenses - Celgene; Pfizer
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
 
Namrata Nayar
No Relationships to Disclose
 
Nicola Jane Lawrence
Travel, Accommodations, Expenses - Roche
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Andrew James Martin
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Nicole Wong
No Relationships to Disclose
 
Annie Yeung
No Relationships to Disclose
 
Michael Friedlander
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Danish Mazhar
No Relationships to Disclose
 
Farzana Pashankar
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Ray McDermott
No Relationships to Disclose
 
Rick Walker
No Relationships to Disclose
 
Mark Winstanley
Travel, Accommodations, Expenses - Merck
 
Fritha J. Hanning
Employment - Canopy Cancer Care
Leadership - Canopy Cancer Care
Stock and Other Ownership Interests - Canopy Cancer Care
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Andrew James Weickhardt
Honoraria - Eisai; Ipsen
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Amanda Gwendolyn Stevanovic
No Relationships to Disclose
 
Ian D. Davis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Exelixis (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Guy C. Toner
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Medivation (Inst)
 
Peter S. Grimison
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); Halozyme (Inst); MSD (Inst); Pfizer (Inst); Specialised Therapeutics (Inst); Tigermed (Inst); Tigermed (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - IPSEN